Please take 5 minutes (really) to complete GDS2016 Mini. 5 minutes which will help us set the scene for GDS2017, launching in November, when we will explore the rise and reinvention of psychedelics, how vaping is changing the way we use drugs, what to do if your mate passes out, where you buy your novel drugs and what you think of drug checking.
GDS 2016 — The results! See what over 100,000 people said about the drugs they take here
GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country.
GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools, designed and analysed by leading experts in the fields of epidemiology, addiction, criminology, toxicology and sociology GDS has access to drug use data from over 500,000 people from over 50 countries.
The GDS sampling frame allows you to effectively compare population segments - young, old, males, females, gay, straight, clubbers, thin people, obese people, vegetarians, those with a current psychiatric symptoms and diagnoses, students, northerners, southerners. GDS helps you better understand the quantitative dynamics of personal decision-making about drug use, detects regional differences in patterns of drug use and related harm, and informs novel interventions.
GDS creates beautiful data reports, digital health assessment tools and free harm reduction resources that aim to make drug use safer regardless of the legal status of the drug GDS reaches hidden, sentinel and hard to reach populations and puts you on top of emerging drug trends in your country and major cities.
Most doctors don't offer warnings or monitor use Doctors' leaders call for prescription drug helpline https://t.co/ZNutONLi7oOpen
Researchers uncover structure of marijuana receptor that makes humans 'high' - Technology & Science - CBC News https://t.co/e8QRTVS7kOOpen
My thoughts - but why bother? Takes the focus off high dose MDMA and simple harm reduction https://t.co/Zet4FOdkisOpen